Results · Apr-Jun 2026 · filed 14 Aug 2026
Aarey Drugs & Pharmaceuticals Q1 FY27 results
Sales fell 56% to ₹44.6 crore from ₹102 crore in Apr-Jun 2025.
Operating profit fell 22% to ₹1.3 crore, an operating margin of 3.0% (up 1.3 points from a year ago).
Net profit fell 25% to ₹1 crore from ₹1.4 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales −76%, net profit −34%.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 44.6 | 102.2 | −56% |
| Operating profit (EBITDA) | 1.3 | 1.7 | −22% |
| Operating margin | 3.0% | 1.7% | +1.3 pts |
| Net profit | 1.0 | 1.4 | −25% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
Filings that week
- 17 Aug 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 14 Aug 2026Unaudited Financial Results For The Quarter Ended 30Th June, 2026
- 14 Aug 2026Board Meeting Outcome for Outcome Of Board Meeting Held On Friday, 14Th August, 2026
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.